Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitamin d Levels and Coronary Catheterization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00749541
Recruitment Status : Completed
First Posted : September 9, 2008
Last Update Posted : December 16, 2010
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center

Tracking Information
First Submitted Date September 7, 2008
First Posted Date September 9, 2008
Last Update Posted Date December 16, 2010
Study Start Date November 2008
Actual Primary Completion Date August 2009   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Vitamin d Levels and Coronary Catheterization
Official Title 25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization
Brief Summary

decreased vitamin d levels are associated with increased inflammatory markers,and renin angiotensin levels.

decreased levels were also found to be connected to increased cardiovascular mortality.

we therefore hypothesise that in patients with pathological results of coronary catheterization we will find decreased levels of 25 hydroxy vitamin d.

we will examine patients undergoing elective coronary catheterization and compare two groups: those with normal results and those with pathological results.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples Without DNA
Description:
blood samples
Sampling Method Probability Sample
Study Population patients undergoing an elective coronary catheterization over the age of 18.
Condition Vitamin D Deficiency
Intervention Not Provided
Study Groups/Cohorts
  • 1normal catheter.
  • abnormal catheter.
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Estimated Enrollment
 (submitted: September¬†8,¬†2008)
100
Original Estimated Enrollment Same as current
Actual Study Completion Date August 2009
Actual Primary Completion Date August 2009   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:age

  • >18 years,
  • no known ihd

Exclusion Criteria:

  • renal failure ,
  • medications including vitamin d, calcium ,phosphate
  • hyper or hypoparathyroidism,
  • abnormal calcium or phosphate values,
  • known pathological coronary catheterization.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT00749541
Other Study ID Numbers vitamin d
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party dr. renana shor, assaf harofeh medical center internal medicine a
Study Sponsor Assaf-Harofeh Medical Center
Collaborators Not Provided
Investigators
Principal Investigator: renana shor, md assaf harofeh mc
PRS Account Assaf-Harofeh Medical Center
Verification Date September 2008